Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.67	132.33	15.37	7.64
Short-Term Investments	247.45	41.39	60.13	-
Cash & Short-Term Investments	281.12	173.72	75.49	7.64
Cash Growth	48.06%	130.12%	888.35%	-
Receivables	2.68	0.48	5.64	1.48
Inventory	2.68	2.16	0.82	0.24
Prepaid Expenses	1.01	1.1	0.09	0.02
Other Current Assets	-	-	-	0.01
Total Current Assets	287.49	177.45	82.03	9.39
Property, Plant & Equipment	0.54	0.8	0.96	0.03
Other Long-Term Assets	4.74	1.15	0.12	0.03
Total Assets	354.25	179.41	83.11	9.45
Accounts Payable	7.57	2.61	1.17	1.36
Accrued Expenses	7.73	6.5	6.61	3.99
Current Portion of Leases	0.31	0.42	0.35	-
Current Unearned Revenue	0.1	0.1	0.1	-
Total Current Liabilities	15.71	9.63	8.23	5.35
Long-Term Leases	-	0.17	0.44	-
Long-Term Unearned Revenue	0.64	0.74	0.79	-
Total Liabilities	16.35	10.54	9.45	5.35
Common Stock	0.03	0.02	-	-
Additional Paid-In Capital	483.14	258.23	1.66	0.14
Retained Earnings	-145.95	-89.42	-45.87	-17.39
Comprehensive Income & Other	0.68	0.05	-0.16	-
Total Common Equity	337.9	168.87	-44.37	-17.25
Shareholders' Equity	337.9	168.87	73.66	4.1
Total Liabilities & Equity	354.25	179.41	83.11	9.45
Total Debt	0.31	0.59	0.79	-
Net Cash (Debt)	280.81	173.13	74.7	7.64
Net Cash Growth	48.42%	131.76%	878.03%	-
Net Cash Per Share	9.96	33.60	85.45	1.91
Filing Date Shares Outstanding	29.6	29.35	4.01	4.01
Total Common Shares Outstanding	29.37	14.82	4.01	4.01
Working Capital	271.78	167.82	73.81	4.04
Book Value Per Share	11.51	11.40	-11.05	-4.31
Tangible Book Value	337.9	168.87	-44.37	-17.25
Tangible Book Value Per Share	11.51	11.40	-11.05	-4.31
Machinery	0.36	0.28	0.17	-
Construction In Progress	-	-	-	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.